Sign in

CIK 0001768224 · Accelerated filer<br>Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
8589002660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale Chief Scientific Officer & COO sold 12,000 shares at $20.76 ($249,121)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Option exercise Director acquired 3,131 shares (option exercise)
  12. 4 Option exercise Director acquired 3,131 shares (option exercise)
  13. 4 Option exercise Director acquired 3,131 shares (option exercise)
  14. 4 Option exercise Director acquired 3,131 shares (option exercise)
  15. 4 Option exercise Director acquired 3,131 shares (option exercise)
  16. 4 Option exercise Director acquired 3,131 shares (option exercise)
  17. 4 Open-market sale Chief Financial Officer sold 50,000 shares at $32.03 ($1,601,500)
  18. 4 Planned sale Chief Scientific Officer & COO sold 114 shares at $45.00 ($5,130)
  19. 4 Planned sale Chief Scientific Officer & COO sold 26,000 shares at $40.01 ($1,040,234)
  20. 4 Planned sale Chief Scientific Officer & COO sold 17,435 shares at $35.02 ($610,574)

Page 2 of 8 · 149 filings